Cyclo Therapeutics Inc (CYTH)
1.40
+0.03
(+2.19%)
USD |
NASDAQ |
May 17, 16:00
1.37
-0.03
(-2.14%)
After-Hours: 20:00
Cyclo Therapeutics Total Liabilities (Quarterly): 8.490M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.490M |
September 30, 2023 | 6.650M |
June 30, 2023 | 6.128M |
March 31, 2023 | 4.536M |
December 31, 2022 | 3.481M |
September 30, 2022 | 2.875M |
June 30, 2022 | 2.102M |
March 31, 2022 | 2.876M |
December 31, 2021 | 3.849M |
September 30, 2021 | 3.470M |
June 30, 2021 | 3.117M |
March 31, 2021 | 3.820M |
December 31, 2020 | 3.736M |
September 30, 2020 | 4.657M |
June 30, 2020 | 4.182M |
March 31, 2020 | 3.984M |
December 31, 2019 | 3.177M |
September 30, 2019 | 2.379M |
June 30, 2019 | 2.751M |
March 31, 2019 | 2.687M |
December 31, 2018 | 1.925M |
September 30, 2018 | 1.655M |
June 30, 2018 | 1.289M |
March 31, 2018 | 1.068M |
December 31, 2017 | 0.943M |
Date | Value |
---|---|
September 30, 2017 | 1.130M |
June 30, 2017 | 0.5664M |
March 31, 2017 | 0.221M |
December 31, 2016 | 0.3425M |
September 30, 2016 | 0.8759M |
June 30, 2016 | 1.123M |
March 31, 2016 | 0.9906M |
December 31, 2015 | 0.9951M |
September 30, 2015 | 1.040M |
June 30, 2015 | 0.8501M |
March 31, 2015 | 0.9071M |
December 31, 2014 | 0.9151M |
September 30, 2014 | 1.008M |
June 30, 2014 | 0.9081M |
March 31, 2014 | 1.008M |
December 31, 2013 | 0.9944M |
September 30, 2013 | 0.9638M |
June 30, 2013 | 1.020M |
March 31, 2013 | 1.129M |
December 31, 2012 | 1.070M |
September 30, 2012 | 1.249M |
June 30, 2012 | 1.298M |
March 31, 2012 | 1.353M |
December 31, 2011 | 1.366M |
September 30, 2011 | 1.052M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.102M
Minimum
Jun 2022
8.490M
Maximum
Dec 2023
4.014M
Average
3.736M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 14.61M |
Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.25M |
Shareholders Equity (Quarterly) | 4.757M |
Current Ratio | 1.455 |